Developing a blood-based gene mutation assay as a novel biomarker for oesophageal adenocarcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Developing a blood-based gene mutation assay as a novel biomarker for oesophageal adenocarcinoma ; volume:9 ; number:1 ; day:26 ; month:3 ; year:2019 ; pages:1-11 ; date:12.2019
Scientific reports ; 9, Heft 1 (26.3.2019), 1-11, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Haboubi, Hasan N.
Lawrence, Rachel L.
Rees, Benjamin
Williams, Lisa
Manson, James M.
Al-Mossawi, Neam
Bodger, Owen
Griffiths, Paul
Thornton, Catherine
Jenkins, Gareth J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-41490-w
- URN
-
urn:nbn:de:101:1-2019041323113114766509
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Haboubi, Hasan N.
- Lawrence, Rachel L.
- Rees, Benjamin
- Williams, Lisa
- Manson, James M.
- Al-Mossawi, Neam
- Bodger, Owen
- Griffiths, Paul
- Thornton, Catherine
- Jenkins, Gareth J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tonsillar metastasis of oesophageal adenocarcinoma
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Calretinin as a blood-based biomarker for mesothelioma
A novel blood-based assay for treatment monitoring of tuberculosis
Oesophageal Adenocarcinoma: A Patient and Physician’s Perspective
Blood-based DNA methylation as biomarker for breast cancer: a systematic review
Biomarker Assay Validation by Mass Spectrometry
Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients
OP570 Blood-based dosimetry in radiopeptide therapy patients using the DSB focus assay [Abstract]
Oesophageal atresia
A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings
Tonsillar metastasis of oesophageal adenocarcinoma
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Calretinin as a blood-based biomarker for mesothelioma
A novel blood-based assay for treatment monitoring of tuberculosis
Oesophageal Adenocarcinoma: A Patient and Physician’s Perspective
Blood-based DNA methylation as biomarker for breast cancer: a systematic review
Biomarker Assay Validation by Mass Spectrometry
Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients
OP570 Blood-based dosimetry in radiopeptide therapy patients using the DSB focus assay [Abstract]
Oesophageal atresia
A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings
Tonsillar metastasis of oesophageal adenocarcinoma
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Calretinin as a blood-based biomarker for mesothelioma
A novel blood-based assay for treatment monitoring of tuberculosis
Oesophageal Adenocarcinoma: A Patient and Physician’s Perspective
Blood-based DNA methylation as biomarker for breast cancer: a systematic review
Biomarker Assay Validation by Mass Spectrometry
Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients
OP570 Blood-based dosimetry in radiopeptide therapy patients using the DSB focus assay [Abstract]
Oesophageal atresia